My aim is to make the reasoning of medical AI systems legible to the clinicians who rely on them.
Dr. Dr. med. Katharina Höbel
Katharina Hoebel is an Independent Research Group Leader funded through the BMFTR “Zukunft eHealth” program. Her group develops interpretable deep learning methods for medical imaging, with a current focus on computational pathology foundation models and glioma subtyping. She studied medicine at Heidelberg University and Kiel University and received her PhD in Medical Engineering and Medical Physics from the Harvard-MIT Division of Health Sciences and Technology. Before joining Hertie AI, she was a postdoctoral fellow at Harvard Medical School and Dana-Farber Cancer Institute. Her work covers uncertainty quantification, expert-centered model evaluation, and spatial modeling of the tumor microenvironment. She received the RSNA Honored Educator Award and the Radiology: Artificial Intelligence Editor’s Recognition Award, and her work has been featured in OncLive.
My aim is to make the reasoning of medical AI systems legible to the clinicians who rely on them.
Present Positions And Title
Independent Research Group Leader
Career
| Period | Institution | Role |
|---|---|---|
| Since 2026 | Hertie Institute for AI in Brain Health, University of Tübingen | Independent Research Group Leader |
| 2024-2026 | Harvard Medical School, Boston, MA, USA | Postdoctoral Research Fellow |
| 2023-2024 | Dana-Faber Cancer Institute, Boston, MA, USArmatics, UKE Hamburg | Postdoctoral Research Fellow |
Academic Education
| Year | Degree | Institution | Field of Study |
|---|---|---|---|
| 2023 | PhD | Massachusetts Institute of Technology (Cambridge, MA, USA) | Medical Physics and Medical Engineering |
| 2017 | Dr. med. | Kiel University | Medicine |
| 2017 | MD | Heidelberg University | Medicine |
| 2016 | B.Sc | Kiel University | Physics |